Although CXCR3 chemokine expression has not yet been compared as a function of BRCA mutation status in human ovarian cancer, our observation is sufficient to explain the higher number of tumour-infiltrating lymphocytes in BRCA-mutated tumours [32]. The gene discussed is CXCR3; the disease is ovarian cancer.